Breaking News

Genentech Ups Investment in Holly Springs Manufacturing Facility to $2B

Expansion will increase production volume and scale manufacturing capacity for next-gen drugs for metabolic conditions.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Genentech

Genentech, a member of the Roche Group, is expanding its initial investment in a new Holly Springs, NC manufacturing facility. The increased investment will more than double the commitment for the company’s first East Coast manufacturing facility to approximately $2 billion. The expansion builds on the company’s May 2025 investment announcement, as well as the project’s August 2025 groundbreaking. Genentech will build out additional production capacity and significantly increase the facility’...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters